diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency or resistance leads to impaired glucose uptake by cells. In Type 1 diabetes, autoimmune destruction of pancreatic beta cells reduces insulin production. In Type 2 diabetes, cells become resistant to insulin, causing the pancreas to overproduce insulin until it can no longer keep up, resulting in hyperglycemia.

• Secondary mechanism: Chronic hyperglycemia causes glycation of proteins and lipids, leading to endothelial dysfunction. This damage to blood vessels contributes to microvascular and macrovascular complications, including nephropathy, retinopathy, and cardiovascular disease.

• Key complication: Persistent high blood sugar levels can lead to diabetic ketoacidosis (DKA) in Type 1 diabetes, a life-threatening condition characterized by the accumulation of ketones and metabolic acidosis. In Type 2 diabetes, hyperosmolar hyperglycemic state (HHS) can occur, marked by extreme dehydration and altered mental status.

Patient Profile

Demographics:

52-year-old male, office manager

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 40 mg daily, Aspirin 81 mg daily

• Allergies: Sulfa drugs

Current Presentation:

• Chief complaint: Increasing numbness and tingling in feet

• Key symptoms: Fatigue, blurry vision, intermittent headaches, frequent urination, increased thirst

• Vital signs: Blood pressure 148/92 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, BMI 32 kg/m²

Section 1

As the patient's symptoms persisted, a comprehensive initial assessment was conducted to further evaluate the extent of his complications. Upon physical examination, the patient exhibited decreased sensation in both feet, consistent with peripheral neuropathy often seen in poorly controlled diabetes. There was also evidence of diminished pedal pulses, indicating possible peripheral artery disease. His blood glucose level was measured at 265 mg/dL, significantly above the target range, and his hemoglobin A1c was found to be 9.2%, indicating poor long-term glycemic control. These findings suggested that the patient's neuropathy and vascular complications were likely progressing due to inadequate diabetes management.

In light of these findings, additional diagnostic tests were ordered to assess the impact of diabetes on other organ systems. A comprehensive metabolic panel revealed an elevated creatinine level of 1.5 mg/dL and a reduced estimated glomerular filtration rate (eGFR) of 55 mL/min/1.73 m², raising concerns about early diabetic nephropathy. A retinal examination was also performed, which showed signs of non-proliferative diabetic retinopathy, including microaneurysms and hemorrhages. These results highlighted the need for a multifaceted approach to manage the patient's diabetes and its complications, emphasizing stricter glycemic control and regular monitoring of kidney function and eye health.

The healthcare team initiated a plan to intensify the patient's diabetes management. This included adjusting his medication regimen to incorporate a sodium-glucose co-transporter-2 (SGLT2) inhibitor to improve glycemic control and provide renal protection. Additionally, lifestyle interventions were emphasized, such as dietary modifications, increased physical activity, and weight loss strategies. The patient was also referred to a podiatrist and ophthalmologist for specialized care. These interventions aimed to prevent further complications and improve the patient's overall quality of life, necessitating ongoing evaluation and adjustment of his treatment plan.

Section 2

Three months after the intensified management plan was implemented, the patient returned for a follow-up evaluation. During this visit, the patient reported improved adherence to the prescribed lifestyle modifications, including dietary changes and increased physical activity. However, he also mentioned experiencing episodes of dizziness and fatigue, particularly when standing up quickly. A physical examination revealed postural hypotension, with blood pressure readings of 130/80 mmHg while seated and 110/70 mmHg upon standing, suggesting a potential side effect of the SGLT2 inhibitor or underlying autonomic neuropathy.

Laboratory tests showed a decrease in blood glucose levels to an average of 180 mg/dL and a reduction in hemoglobin A1c to 8.0%, indicating some improvement in glycemic control. However, the metabolic panel revealed a slight increase in creatinine to 1.7 mg/dL, and the eGFR had fallen to 50 mL/min/1.73 m², raising further concerns about the progression of diabetic nephropathy. Additionally, the lipid profile indicated elevated LDL cholesterol levels at 130 mg/dL, warranting consideration for statin therapy to reduce cardiovascular risk.

In response to these new findings, the healthcare team decided to adjust the patient's medication regimen. The dosage of the SGLT2 inhibitor was re-evaluated to mitigate the risk of hypotension, and a low-dose ACE inhibitor was introduced to help protect kidney function. The patient was also started on a statin to address dyslipidemia. Education on recognizing and managing symptoms of orthostatic hypotension was provided. The team emphasized the importance of continued monitoring for potential side effects and adherence to lifestyle modifications. These adjustments aimed to optimize the patient's management plan, highlighting the need for a dynamic approach in addressing the evolving complexities of diabetes and its complications.

Section 3

Two months following the adjustment of the patient's medication regimen, the patient returned for another follow-up visit. During this visit, he reported a noticeable reduction in episodes of dizziness and fatigue, suggesting a positive response to the modified dosage of the SGLT2 inhibitor and the introduction of the ACE inhibitor. However, he expressed new concerns about experiencing intermittent tingling and a burning sensation in his feet, particularly at night. This development prompted the healthcare team to consider the possibility of diabetic neuropathy—a common complication in diabetes that can lead to significant discomfort and impact quality of life.

A thorough neurological examination was conducted, revealing decreased vibratory sensation in the patient's toes and diminished ankle reflexes, further supporting the suspicion of peripheral neuropathy. In response, the healthcare team discussed potential treatment options to alleviate the patient's symptoms, including the introduction of a medication specifically for neuropathic pain, such as gabapentin, while emphasizing the importance of maintaining optimal glycemic control to slow the progression of neuropathy.

Laboratory tests during this visit showed a slight improvement in the patient's lipid profile, with LDL cholesterol levels reduced to 110 mg/dL, reflecting some positive impact of the statin therapy. However, kidney function remained a concern, with creatinine levels stabilizing at 1.6 mg/dL and eGFR holding steady at 52 mL/min/1.73 m², underscoring the need for continued monitoring and potential future adjustments to the treatment plan. The healthcare team reinforced the importance of ongoing lifestyle modifications and regular follow-up visits to manage these emerging complications effectively. The patient was encouraged to remain vigilant about monitoring symptoms and to report any further changes promptly, ensuring a proactive approach to managing his diabetes and associated complications.

Section 4

Two months after initiating gabapentin for neuropathic pain, the patient returned for a routine follow-up visit. During this appointment, he reported a moderate reduction in the burning sensation in his feet, indicating a partial improvement in his symptoms. However, he also mentioned experiencing occasional bouts of nausea and dizziness, particularly upon standing, which raised concerns about potential side effects from the medication regimen. Vital signs recorded during the visit showed a blood pressure of 108/68 mmHg and a heart rate of 88 beats per minute, suggesting a possibility of orthostatic hypotension, likely related to the combined effects of the ACE inhibitor and the SGLT2 inhibitor.

In light of these findings, the healthcare team conducted a detailed review of the patient's medication schedule and made adjustments to minimize potential adverse effects. The team decided to reduce the dosage of the ACE inhibitor, with careful monitoring of blood pressure levels to ensure stability without compromising renal protection. Additionally, the team advised the patient to rise slowly from sitting or lying positions to mitigate dizziness and prevent falls. Laboratory tests from this visit revealed a slight decrease in hemoglobin A1c, now at 7.2%, indicating some improvement in glycemic control. However, the patient's kidney function showed a minor decline, with eGFR dropping to 50 mL/min/1.73 m², prompting a discussion about the need for ongoing renal monitoring and potential future interventions.

The healthcare team emphasized the importance of continued adherence to lifestyle modifications, including dietary adjustments and regular exercise, to support overall health and slow the progression of diabetes-related complications. The patient was encouraged to keep a symptom diary to track any new or worsening symptoms, providing valuable information for future consultations. This proactive approach aimed to refine the patient's management plan and address emerging complications effectively, setting the stage for the next phase of his journey in managing diabetes and associated health challenges.

Section 5

Two months following the medication adjustments, the patient returned for another follow-up visit, expressing concerns about new complications. He reported increased episodes of fatigue and swelling in his ankles, particularly noticeable in the evenings. During the physical examination, the healthcare team observed bilateral pitting edema in the patient's lower extremities, raising concerns about potential fluid retention. Vital signs during this visit indicated a blood pressure of 110/70 mmHg and a heart rate of 92 beats per minute, remaining stable but with a subtle increase in pulse rate. These findings prompted the team to consider the possibility of heart complications, as well as the need to evaluate the patient’s cardiac and renal status more thoroughly.

Laboratory tests were ordered to assess cardiac function and to monitor the progression of renal impairment. Results showed an increase in B-type natriuretic peptide (BNP) levels, suggesting potential heart strain or the early stages of heart failure. Additionally, the patient’s eGFR had further decreased to 45 mL/min/1.73 m², indicating a progressive decline in kidney function. These findings necessitated a reevaluation of the patient's treatment plan, with a focus on optimizing cardiovascular and renal health. The healthcare team discussed the potential need for a cardiology referral and considered the initiation of a diuretic to manage fluid retention while carefully balancing renal perfusion.

In response to these developments, the patient was advised to monitor his weight daily to detect any significant changes that might indicate fluid buildup. The healthcare team also reinforced the importance of adhering to the prescribed low-sodium diet and engaging in regular, low-impact exercise to support cardiovascular health. The patient was counseled on recognizing signs of worsening heart or kidney function, such as increased shortness of breath or significant weight gain over a short period. This vigilant approach aimed to preemptively address the emerging complications, ensuring timely interventions and adjustments to the management plan. The patient expressed understanding and commitment to these recommendations, setting the stage for the next steps in his ongoing care journey.